biospecimen__admin__batch_number	203.73.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	C78E417C-D1A6-4876-9AC0-2FAF117ADBD2
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-A1EK-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-A1EK-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-DD-A1EK-01A
biospecimen__bio__biospecimen_barcode_bottom	0122967799
biospecimen__bio__day_of_creation	31
biospecimen__bio__day_of_shipment	24
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	01
biospecimen__bio__month_of_shipment	01
biospecimen__bio__pathology_report_file_name	TCGA-DD-A1EK.AE199A35-2585-4363-8896-9B55B12C1BDF.pdf
biospecimen__bio__plate_column	8
biospecimen__bio__plate_id	A214
biospecimen__bio__plate_row	D
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.20
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2011
biospecimen__bio__year_of_shipment	2012
biospecimen__shared__bcr_patient_barcode	TCGA-DD-A1EK
biospecimen__shared__patient_id	A1EK
clinical__ablation__ablation_performed_indicator	YES
clinical__ablation__ablation_type	Radiofrequency Ablation
clinical__ablation__bcr_ablation_barcode	TCGA-DD-A1EK-A42206
clinical__ablation__bcr_ablation_uuid	61C165ED-E7E2-41EE-B4E9-C9368BA49FAC
clinical__ablation__days_to_ablation_performed	0
clinical__ablation__days_to_embolization_performed	286
clinical__ablation__embolization_performed_indicator	YES
clinical__ablation__embolization_type	Chemoembolization
clinical__ablation__lesions_count	3
clinical__ablation__treatment_cycles_count	1
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	3DECCCFE-20E3-4EA3-B033-62F6FEC3F9E7
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	4.3
clinical__chol_lihc_shared__albumin_result_upper_limit	5.0
clinical__chol_lihc_shared__bilirubin_lower_limit	0.1
clinical__chol_lihc_shared__bilirubin_upper_limit	0.5
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.6
clinical__chol_lihc_shared__creatinine_upper_limit	1.1
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.7
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	6
clinical__chol_lihc_shared__fetoprotein_outcome_value	19
clinical__chol_lihc_shared__fibrosis_ishak_score	0 - No Fibrosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Other
clinical__chol_lihc_shared__hist_hepato_carcinoma_risk	tobacco, birth control bills
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	8.3
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	10.8
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	450
clinical__chol_lihc_shared__prothrombin_time_result_value	10.3
clinical__chol_lihc_shared__specimen_collection_method_name	Segmentectomy, Multiple
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.0
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	64
clinical__clin_shared__bcr_followup_barcode	TCGA-DD-A1EK-F42001
clinical__clin_shared__bcr_followup_uuid	2AA7B806-A0E6-4200-BA48-E19624E72226
clinical__clin_shared__cancer_first_degree_relative	1
clinical__clin_shared__day_of_form_completion	9
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__measure_of_response	Clinical Progressive Disease
clinical__clin_shared__month_of_form_completion	4
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__platelet_result_count	387
clinical__clin_shared__post_op_ablation_embolization_tx	YES
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis B Surface Antigen
clinical__clin_shared__year_of_form_completion	2013
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2008
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Mild
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	Yes
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	YES
clinical__nte__additional_radiation_therapy	NO
clinical__nte__days_to_new_tumor_event_after_initial_treatment	167
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Liver
clinical__nte__new_neoplasm_event_type	Locoregional Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__rx__bcr_drug_barcode	TCGA-DD-A1EK-D42207
clinical__rx__bcr_drug_uuid	91BF0C5B-D368-4354-930D-07933F900F0F
clinical__rx__days_to_drug_therapy_end	349
clinical__rx__days_to_drug_therapy_start	188
clinical__rx__drug_name	Sorafenib
clinical__rx__therapy_ongoing	NO
clinical__rx__therapy_type	Chemotherapy
clinical__rx__tx_on_clinical_trial	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M1
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T4
clinical__shared_stage__system_version	6th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	42f78f85-4895-4342-9ec8-76b7fe369a4c
gdc__aliquots__concentration	0.16
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-A1EK-01A-11R-A214-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	33d9fee2-2a43-4d13-aa10-ba64a1294d81
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.69
gdc__analytes__analyte_id	0664aa09-976d-4d63-ba6d-4c5f6d396631
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	a5e4412b-0e49-4d86-9cce-71f440a84048
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:49:30.029218-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	e3291248-4410-5e59-a6da-98387aaabf1d
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	female
gdc__demographic__race	white
gdc__demographic__year_of_birth	1944
gdc__demographic__year_of_death	2009
gdc__diagnoses__age_at_diagnosis	23437
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-23437.0
gdc__diagnoses__days_to_death	558.0
gdc__diagnoses__diagnosis_id	8dc59b50-8cb6-5c99-9b8f-d8d09fa9bff6
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage ivb
gdc__diagnoses__vital_status	dead
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	38.36873541394723
gdc__exposures__exposure_id	d789a9fc-eb21-514e-905a-786c7817b3c6
gdc__exposures__height	159.0
gdc__exposures__weight	97.0
gdc__file_id	604d8e17-2298-4af5-acb9-d644cae937d9
gdc__file_name	5ef61536-fc67-417b-a93a-521c0a518441.mirbase21.mirnas.quantification.txt
gdc__file_size	50426
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	dc140fd13831e4be1b8b5b1536d9c28a
gdc__portions__is_ffpe	false
gdc__portions__portion_id	1e1c6bf9-a90d-49c2-a18a-ddf9c98242e6
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	819
gdc__samples__initial_weight	40.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	AE199A35-2585-4363-8896-9B55B12C1BDF
gdc__samples__sample_id	71ccf91a-f2af-4c6b-a22f-769f4cc96163
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	5.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	5.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	20.0
gdc__slides__percent_tumor_cells	75.0
gdc__slides__percent_tumor_nuclei	80.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	1b00ff76-1ddd-4e73-912f-a1154bf217b6
gdc__submitter_id	mirna_swap_dr11_365_MirnaExpression64c69d3f-6207-4ec1-816b-6bed1a459dc5_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	21a3360f-2df3-53b6-8eda-dadfce3485b4
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:08:04.476+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/42f78f85-4895-4342-9ec8-76b7fe369a4c-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/42f78f85-4895-4342-9ec8-76b7fe369a4c-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129797
manually_curated__local_md5	72c873d77aa0ed76c3eb5c3622217ab5
manually_curated__opengdc_download_date	2018-10-16T17:12:52.000930+02:00
manually_curated__opengdc_file_md5	96319480ed6c37685dddb5386f4d9825
manually_curated__opengdc_file_size	50425
manually_curated__opengdc_id	42f78f85-4895-4342-9ec8-76b7fe369a4c-meq
manually_curated__origin_file_size	129797
manually_curated__origin_last_modified_date	Tue Oct 16 18:03:00 CEST 2018
manually_curated__origin_md5	72c873d77aa0ed76c3eb5c3622217ab5
manually_curated__tissue_status	tumoral
